Sheba Awarded NIS 10M Grant to Launch BioConvergence Hub for Medical Innovation
The Sheba BioConvergence Hub will serve as a unique meeting point for researchers, physicians, academic institutions, medical industry leaders, and technology partners. Its primary goal will be to drive development processes that transform early-stage research into real-world clinical applications, advancing next-generation therapies and healthcare services.
Operating within the HealthTech Valley, currently under development adjacent to Sheba Medical Center, the hub will play a key role in realizing Sheba’s broader vision of a “City of Health.” This ecosystem will bring together innovation, research, and patient care under one integrated model.
From Research to Real-World Care
By focusing on the “bench to bedside” model, the BioConvergence Hub is set to accelerate the translation of ideas into impact. The initiative supports the creation of new therapies and technologies that will benefit patients in Israel and worldwide.
This grant recognizes Sheba’s leadership in medical innovation and supports its mission to foster a healthcare environment where research, technology, and clinical care are seamlessly connected.
A Magnet for Global Collaboration
HealthTech Valley, where the hub will be located, is envisioned as a global destination for entrepreneurs, research institutions, academic bodies, and biomedical and biotech companies. With the addition of the BioConvergence Hub, it will become a collaborative engine for advancing healthcare solutions with global reach.
By bridging cutting-edge research and clinical practice, the hub underscores Sheba’s commitment to shaping the future of medicine, both locally and internationally.
A Vision for the Future of Medicine
The establishment of the Sheba BioConvergence Hub marks a new milestone in Sheba’s innovation journey. It reflects Sheba’s continued efforts to build a healthcare ecosystem driven by collaboration, creativity, and commitment to global health advancement.


